<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04643899</url>
  </required_header>
  <id_info>
    <org_study_id>ILDYS-ISC2-2020001</org_study_id>
    <secondary_id>ID-RCB</secondary_id>
    <nct_id>NCT04643899</nct_id>
  </id_info>
  <brief_title>Effects of Electrostimulation on Glycemic Control in Obesity</brief_title>
  <acronym>ElectrOBA</acronym>
  <official_title>Evaluation of the Effects of Electrical Muscle Stimulation on Carbohydrate Homeostasis in Adult Patients With Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ildys</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondation Ildys</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the effects of muscle electrostimulation (MES) on carbohydrate&#xD;
      homeostasis in adult patients with obesity. Its aims are also to evaluate the tolerance of&#xD;
      feasibilty and the tolerance of MES and the impact on basal metabolism ; muscle mass&#xD;
      (maintenance, gain or loss) in a context of calorie restriction ; physical capacities ;&#xD;
      adherence to the usual rehabilitation program ; eating behavior : quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prevalence of adult obesity in general french population (≈15%) justifies the implementation&#xD;
      of innovative care. Prescribing regular physical activity is one of the recommendations for&#xD;
      managing obesity. However, patients find it difficult because of non-adapted offered&#xD;
      activities; non-achievement concrete results despite the effort; difficulties to manage&#xD;
      activities and to plan objective. Situation is seen as a failure and discourages patients. In&#xD;
      addition, the obese patient may suffer from orthopedic disorders, cardiovascular&#xD;
      contraindications, and the excessive weight in itself may force him to become sedentary. The&#xD;
      recommendations on the practice of physical activity in the overall management of obesity are&#xD;
      therefore not always applicable.&#xD;
&#xD;
      Muscle electrostimulation (MES) could therefore be an interesting additional tool in the&#xD;
      management of obesity and particularly of glycemic control in obese patients suffering from&#xD;
      type 2 diabetes.&#xD;
&#xD;
      Studies are still relatively few and present certain limits (small samples, short period of&#xD;
      MES, very specific populations, few parameters evaluated, lack of consensus on the methods of&#xD;
      MES, etc.). The results are nevertheless encouraging and call for the implementation of&#xD;
      additional studies.&#xD;
&#xD;
      Investigators therefore propose a controlled, randomized, single-center study in a group of&#xD;
      60 adult patients suffering from severe or morbid obesity (BMI&gt; = 35) in a 3-week&#xD;
      rehabilitation stay.&#xD;
&#xD;
      The aims are to establish whether MES is a possible and interesting tool in the management of&#xD;
      obesity, by checking the following hypotheses:&#xD;
&#xD;
        -  control of carbohydrate metabolism is better when a MES is implemented;&#xD;
&#xD;
        -  MES sessions improve patients' physical capacities and / or their tolerance to exercise;&#xD;
&#xD;
        -  MES improves the quality of life of patients;&#xD;
&#xD;
        -  MES improves patient adherence to the usual nutritional rehabilitation program;&#xD;
&#xD;
        -  MES sessions are well tolerated and the accepted intensity nevertheless guarantees&#xD;
           sufficient muscle stimulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Monocentric; prospective; opened ; randomized; controlled study&#xD;
Distribution of patients in groups according to a ratio (1: 1)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Carbohydrate balance</measure>
    <time_frame>Continuous measurement over the entire stay (Day 1 to Day 21)</time_frame>
    <description>Evaluation of the time spent (%) above / in / below the patient's glycemic targets measured with a &quot;Free Style&quot; glycemic holter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Homa Index</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 21)</time_frame>
    <description>Insulin resistance assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quicki Index</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 21)</time_frame>
    <description>Insulin sensitivity assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Glucose Levels</measure>
    <time_frame>Continuous measurement over the entire stay (Day 1 to Day 21)</time_frame>
    <description>Evaluation of the glucose levels (average, minimum, maximum)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial blood glucose</measure>
    <time_frame>Continuous measurement over the entire stay (Day 1 to Day 21)</time_frame>
    <description>Assessment of the number of postprandial hyper and hypoglycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basal blood metabolism</measure>
    <time_frame>Change from baseline (Day 2) to week 3 (Day 21)</time_frame>
    <description>Blood chemistry analysis (lipid balance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impedance</measure>
    <time_frame>Change from baseline (Day 2) to week 3 (Day 20)</time_frame>
    <description>Bioelectrical impedance analysis of body composition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal voluntary force</measure>
    <time_frame>Change from baseline (Day 2) to week 3 (Day 21)</time_frame>
    <description>Measurement of the maximum voluntary strength and endurance of the quadriceps</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minutes walk test (6MWT)</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 20)</time_frame>
    <description>Measurement of the distance traveled during the 6MWT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&quot;Ricci &amp; Gagnon&quot; questionnaire</measure>
    <time_frame>Change from baseline (Day 2) to week 3 (Day 21)</time_frame>
    <description>Assessment of the level of physical activities and sedentary lifestyle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to the rehabilitation program</measure>
    <time_frame>Evaluation at each sessions from Day 1 to Day 21</time_frame>
    <description>Evaluation of the number of performed sessions compared to the expected for the proposed activities (collective balneotherapy, individual balneotherapy, supervised adapted physical activities, independent nordic walking) with analysis of the reasons for the differences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 21)</time_frame>
    <description>Weight (Kg) and height (cm) will be combined to report BMI in kg/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life, obesity and dietetics (QOLOD) rating scale</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 21)</time_frame>
    <description>Evaluation of quality of life - This scale gives 5 sub-scores ranging from 0 (worse outcome) to 100 (better outcome) for each explored dimension.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog pain scale</measure>
    <time_frame>Evaluation at each sessions from Day 2 to Day 20</time_frame>
    <description>Assessment of pain intensity during MES sessions with a visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MES sessions check</measure>
    <time_frame>Change from baseline (Day 1) to week 3 (Day 21)</time_frame>
    <description>Record of session criteria (duration, program, maximum intensity, contraction Y/N)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Obesity Adult Onset</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients benefiting only from the usual nutritional rehabilitation program G1a: diabetic patients G1b: non-diabetic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrostimulation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients benefiting from the usual program AND muscle electrostimulation sessions G2a: diabetic patients G2b: non-diabetic patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Muscle Electrostimulation</intervention_name>
    <description>Scheduled sessions of 20 minutes per day; 5 days a week&#xD;
In physiotherapy or in their room for the most dependent patients&#xD;
Installation and monitoring by a physiotherapist or by the trained clinical research nurse&#xD;
Modalities:&#xD;
Device program n ° 1: 20mn (2mn of warm-up, 15mn of work at 75hz, then 3mn of recovery)&#xD;
4 electrodes (2 per thigh): large model (5 * 10 cm) for better comfort - Dura-Stick Plus model (reference 42200)&#xD;
Gradual auto-increase of the intensity to the highest possible value tolerated, nevertheless allowing a contraction</description>
    <arm_group_label>Electrostimulation group</arm_group_label>
    <other_name>Compex Pro Rehab ®</other_name>
    <other_name>253311x - REF 201010</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  men and women over 18 years old and under 70 years old&#xD;
&#xD;
          -  with severe or morbid obesity (BMI&gt; = 35)&#xD;
&#xD;
          -  with or without bariatric surgery&#xD;
&#xD;
          -  able to understand and respect the protocol and its requirement&#xD;
&#xD;
          -  who signed the consent prior to any other procedure protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  major patients under guardianship / curatorship / legal protection&#xD;
&#xD;
          -  pregnant patients&#xD;
&#xD;
          -  patients with epilepsy&#xD;
&#xD;
          -  with an implanted electronic/electrical device (cardiac pacemaker, intracardiac&#xD;
             defibrillator, etc.)&#xD;
&#xD;
          -  with a baclofen pump&#xD;
&#xD;
          -  suffering from serious disorders of the arterial circulation in the lower limbs such&#xD;
             as Peripheral Arterial Obstructive Disease (PAOD)&#xD;
&#xD;
          -  suffering from abdominal or inguinal hernia&#xD;
&#xD;
          -  suffering from cardiac arrhythmia&#xD;
&#xD;
          -  suffering from skin lesions and/or infections foci on one or more areas where the&#xD;
             electrodes are placed&#xD;
&#xD;
          -  suffering from sensory disorders in the areas of stimulation&#xD;
&#xD;
          -  patients unable to complete the entire program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lena SEITE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ildys</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laetitia GUEGANTON, PhD</last_name>
    <phone>33-6-13-61-78-46</phone>
    <email>laetitia.gueganton@ildys.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marion BUYSE, MD</last_name>
    <phone>33-2-98-29-34-47</phone>
    <email>marion.buyse@ildys.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CF Center - Fondation Ildys Site de Perharidy</name>
      <address>
        <city>Roscoff</city>
        <zip>29684</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Grosset JF, Crowe L, De Vito G, O'Shea D, Caulfield B. Comparative effect of a 1 h session of electrical muscle stimulation and walking activity on energy expenditure and substrate oxidation in obese subjects. Appl Physiol Nutr Metab. 2013 Jan;38(1):57-65. doi: 10.1139/apnm-2011-0367. Epub 2012 Nov 12.</citation>
    <PMID>23368829</PMID>
  </reference>
  <reference>
    <citation>van Buuren F, Horstkotte D, Mellwig KP, Fründ A, Vlachojannis M, Bogunovic N, Dimitriadis Z, Vortherms J, Humphrey R, Niebauer J. Electrical Myostimulation (EMS) Improves Glucose Metabolism and Oxygen Uptake in Type 2 Diabetes Mellitus Patients--Results from the EMS Study. Diabetes Technol Ther. 2015 Jun;17(6):413-9. doi: 10.1089/dia.2014.0315. Epub 2015 Mar 3.</citation>
    <PMID>25734937</PMID>
  </reference>
  <reference>
    <citation>Joubert M, Metayer L, Prevost G, Morera J, Rod A, Cailleux A, Parienti JJ, Reznik Y. Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot study. Acta Diabetol. 2015 Apr;52(2):285-91. doi: 10.1007/s00592-014-0636-5. Epub 2014 Aug 9.</citation>
    <PMID>25107502</PMID>
  </reference>
  <reference>
    <citation>Miyamoto T, Fukuda K, Kimura T, Matsubara Y, Tsuda K, Moritani T. Effect of percutaneous electrical muscle stimulation on postprandial hyperglycemia in type 2 diabetes. Diabetes Res Clin Pract. 2012 Jun;96(3):306-12. doi: 10.1016/j.diabres.2012.01.006. Epub 2012 Jan 30.</citation>
    <PMID>22296854</PMID>
  </reference>
  <reference>
    <citation>Vivodtzev I, Maffiuletti NA, Borel AL, Grangier A, Wuyam B, Tamisier R, Pépin JL. Acute Feasibility of Neuromuscular Electrical Stimulation in Severely Obese Patients with Obstructive Sleep Apnea Syndrome: A Pilot Study. Biomed Res Int. 2017;2017:3704380. doi: 10.1155/2017/3704380. Epub 2017 Jan 17.</citation>
    <PMID>28194410</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 29, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>muscle electrostimulation</keyword>
  <keyword>diabetes</keyword>
  <keyword>endocrinology</keyword>
  <keyword>physical activity</keyword>
  <keyword>quality of life</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

